{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:42:16Z","timestamp":1786984936963,"version":"build-2736575974"},"reference-count":137,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2021JJ40277"],"award-info":[{"award-number":["2021JJ40277"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82101962"],"award-info":[{"award-number":["82101962"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82470757"],"award-info":[{"award-number":["82470757"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.autrev.2025.103821","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T02:49:13Z","timestamp":1745376553000},"page":"103821","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["The role of double-negative B cells in the pathogenesis of systemic lupus erythematosus"],"prefix":"10.1016","volume":"24","author":[{"given":"Xinying","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RuiFan","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jueyi","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasnim","family":"Azad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junquan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haotian","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimsor","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binbin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2025.103821_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102861","article-title":"Autoantibodies in systemic lupus erythematosus: from immunopathology to therapeutic target","volume":"132","author":"Lou","year":"2022","journal-title":"J Autoimmun"},{"issue":"11","key":"10.1016\/j.autrev.2025.103821_bb0010","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1136\/annrheumdis-2012-201940","article-title":"Joint European league against rheumatism and European renal association-European dialysis and transplant association (EULAR\/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis","volume":"71","author":"Bertsias","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.autrev.2025.103821_bb0015","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41584-021-00668-1","article-title":"Global epidemiology of systemic lupus erythematosus","volume":"17","author":"Barber","year":"2021","journal-title":"Nat Rev Rheumatol"},{"issue":"18","key":"10.1016\/j.autrev.2025.103821_bb0020","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adn6537","article-title":"Altered X-chromosome inactivation predisposes to autoimmunity","volume":"10","author":"Huret","year":"2024","journal-title":"Sci Adv"},{"issue":"11","key":"10.1016\/j.autrev.2025.103821_bb0025","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M17-0102","article-title":"46-year trends in systemic lupus erythematosus mortality in the United States, 1968 to 2013: a nationwide population-based study","volume":"167","author":"Yen","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2025.103821_bb0030","article-title":"Progress of rituximab in the treatment of systemic lupus erythematosus and lupus nephritis","volume":"11","author":"Mo","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.autrev.2025.103821_bb0035","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.39","article-title":"Systemic lupus erythematosus","volume":"2","author":"Kaul","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"10.1016\/j.autrev.2025.103821_bb0040","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0889-857X(05)70137-X","article-title":"Genetics of systemic lupus erythematosus. Clinical implications","volume":"26","author":"Sullivan","year":"2000","journal-title":"Rheum Dis Clin North Am"},{"issue":"5","key":"10.1016\/j.autrev.2025.103821_bb0045","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1084\/jem.20151724","article-title":"B cell IFN-\u03b3 receptor signaling promotes autoimmune germinal centers via cell-intrinsic induction of BCL-6","volume":"213","author":"Jackson","year":"2016","journal-title":"J Exp Med"},{"issue":"22","key":"10.1016\/j.autrev.2025.103821_bb0050","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMra1100359","article-title":"Systemic lupus erythematosus","volume":"365","author":"Tsokos","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2025.103821_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1155421","article-title":"B cell activation via immunometabolism in systemic lupus erythematosus","volume":"14","author":"Iwata","year":"2023","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2025.103821_bb0060","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a007146","article-title":"Central B-cell tolerance: where selection begins","volume":"4","author":"Pelanda","year":"2012","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"6","key":"10.1016\/j.autrev.2025.103821_bb0065","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.immuni.2004.05.010","article-title":"Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches","volume":"20","author":"Thien","year":"2004","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.autrev.2025.103821_bb0070","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.immuni.2020.04.015","article-title":"Plasmacytoid dendritic cells and type I interferon promote extrafollicular B cell responses to extracellular self-DNA","volume":"52","author":"Soni","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2025.103821_bb0075","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3389\/fimmu.2017.00775","article-title":"TLR7\/TLR9- and B cell receptor-signaling crosstalk: promotion of potentially dangerous B cells","volume":"8","author":"Suthers","year":"2017","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103821_bb0080","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1038\/s41467-018-03750-7","article-title":"IL-21 drives expansion and plasma cell differentiation of autoreactive CD11c(hi)T-bet(+) B cells in SLE","volume":"9","author":"Wang","year":"2018","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.autrev.2025.103821_bb0085","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nri3190","article-title":"Integration of B cell responses through toll-like receptors and antigen receptors","volume":"12","author":"Rawlings","year":"2012","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"10.1016\/j.autrev.2025.103821_bb0090","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1084\/jem.20050630","article-title":"RNA-associated autoantigens activate B cells by combined B cell antigen receptor\/toll-like receptor 7 engagement","volume":"202","author":"Lau","year":"2005","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.autrev.2025.103821_bb0095","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.immuni.2018.08.015","article-title":"Distinct effector B cells induced by unregulated toll-like receptor 7 contribute to pathogenic responses in systemic lupus erythematosus","volume":"49","author":"Jenks","year":"2018","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.autrev.2025.103821_bb0100","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1136\/ard.2005.046052","article-title":"Cigarette smoking and the risk of systemic lupus erythematosus and rheumatoid arthritis","volume":"65","author":"Majka","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.autrev.2025.103821_bb0105","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.4049\/jimmunol.0901297","article-title":"Atypical memory B cells are greatly expanded in individuals living in a malaria-endemic area","volume":"183","author":"Weiss","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2025.103821_bb0110","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.imlet.2023.03.003","article-title":"IgD(\u2212)CD27(\u2212) double negative (DN) B cells: origins and functions in health and disease","volume":"255","author":"Beckers","year":"2023","journal-title":"Immunol Lett"},{"issue":"2","key":"10.1016\/j.autrev.2025.103821_bb0115","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/cei.13615","article-title":"Double-negative (DN) B cells: an under-recognized effector memory B cell subset in autoimmunity","volume":"205","author":"Li","year":"2021","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2025.103821_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-021-02557-0","article-title":"The expansion of activated naive DNA autoreactive B cells and its association with disease activity in systemic lupus erythematosus patients","volume":"23","author":"Wangriatisak","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2025.103821_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.826152","article-title":"Rituximab in systemic lupus erythematosus: transient effects on autoimmunity associated lymphocyte phenotypes and implications for immunogenicity","volume":"13","author":"Faustini","year":"2022","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.autrev.2025.103821_bb0130","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202217341","article-title":"Functions of double-negative B cells in autoimmune diseases, infections, and cancers","volume":"15","author":"Chung","year":"2023","journal-title":"EMBO Mol Med"},{"issue":"1","key":"10.1016\/j.autrev.2025.103821_bb0135","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jaci.2023.10.009","article-title":"Emerging insights into atypical B cells in pediatric chronic infectious diseases and immune system disorders: T(o)-bet on control of B-cell immune activation","volume":"153","author":"Olivieri","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2025.103821_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.988125","article-title":"Autoantibodies elicited with SARS-CoV-2 infection are linked to alterations in double negative B cells","volume":"13","author":"Castleman","year":"2022","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.autrev.2025.103821_bb0145","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1136\/annrheumdis-2021-220349","article-title":"B cell subset composition segments clinically and serologically distinct groups in chronic cutaneous lupus erythematosus","volume":"80","author":"Jenks","year":"2021","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.autrev.2025.103821_bb0150","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/s41590-020-00814-z","article-title":"Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19","volume":"21","author":"Woodruff","year":"2020","journal-title":"Nat Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103821_bb0155","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cell.2020.08.025","article-title":"Loss of Bcl-6-expressing T follicular helper cells and germinal centers in COVID-19","volume":"183","author":"Kaneko","year":"2020","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.autrev.2025.103821_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112630","article-title":"Extrafollicular IgD(\u2212)CD27(\u2212)CXCR5(\u2212)CD11c(\u2212) DN3 B cells infiltrate inflamed tissues in autoimmune fibrosis and in severe COVID-19","volume":"42","author":"Allard-Chamard","year":"2023","journal-title":"Cell Rep"},{"key":"10.1016\/j.autrev.2025.103821_bb0165","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.602539","article-title":"Single-cell transcriptomic analyses define distinct peripheral B cell subsets and discrete development pathways","volume":"12","author":"Stewart","year":"2021","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.autrev.2025.103821_bb0170","doi-asserted-by":"crossref","first-page":"6667","DOI":"10.3390\/cimb45080421","article-title":"Increase in double negative B lymphocytes in patients with systemic lupus erythematosus in remission and their correlation with early differentiated T lymphocyte subpopulations","volume":"45","author":"Moysidou","year":"2023","journal-title":"Curr Issues Mol Biol"},{"issue":"9","key":"10.1016\/j.autrev.2025.103821_bb0175","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/s41590-020-0743-0","article-title":"Mapping systemic lupus erythematosus heterogeneity at the single-cell level","volume":"21","author":"Nehar-Belaid","year":"2020","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2025.103821_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.606338","article-title":"Specific induction of double negative B cells during protective and pathogenic immune responses","volume":"11","author":"Ruschil","year":"2020","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2025.103821_bb0185","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2019097118","article-title":"Acute skin exposure to ultraviolet light triggers neutrophil-mediated kidney inflammation","volume":"118","author":"Skopelja-Gardner","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.autrev.2025.103821_bb0190","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/intimm\/dxac042","article-title":"The proliferative activity levels of each immune cell population evaluated by mass cytometry are linked to the clinical phenotypes of systemic lupus erythematosus","volume":"35","author":"Kajihara","year":"2023","journal-title":"Int Immunol"},{"issue":"73","key":"10.1016\/j.autrev.2025.103821_bb0195","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abq3277","article-title":"Human T-bet governs the generation of a distinct subset of CD11c(high)CD21(low) B cells","volume":"7","author":"Yang","year":"2022","journal-title":"Sci Immunol"},{"key":"10.1016\/j.autrev.2025.103821_bb0200","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1235937","article-title":"BAFF system expression in double negative 2, activated na\u00efve and activated memory B cells in systemic lupus erythematosus","volume":"14","author":"\u00c1lvarez G\u00f3mez","year":"2023","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2025.103821_bb0205","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1093\/rheumatology\/keac528","article-title":"SLE stratification based on BAFF and IFN-I bioactivity for biologics and implications of BAFF produced by glomeruli in lupus nephritis","volume":"62","author":"Itotagawa","year":"2023","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.autrev.2025.103821_bb0210","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1074-7613(04)00079-2","article-title":"Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF","volume":"20","author":"Lesley","year":"2004","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.autrev.2025.103821_bb0215","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.1093\/rheumatology\/keab381","article-title":"Phase 2, randomized, placebo-controlled trial of dapirolizumab pegol in patients with moderate-to-severe active systemic lupus erythematosus","volume":"60","author":"Furie","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2025.103821_bb0220","article-title":"IFN-\u03b3, should not be ignored in SLE","volume":"13","author":"Liu","year":"2022","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2025.103821_bb0225","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/BOR.0b013e3283562c3e","article-title":"Type I IFN system in the development and manifestations of SLE","volume":"24","author":"Elkon","year":"2012","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103821_bb0230","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41572-019-0141-9","article-title":"Lupus nephritis","volume":"6","author":"Anders","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.autrev.2025.103821_bb0235","first-page":"8","article-title":"IFN\u03b3 induces epigenetic programming of human T-bet(hi) B cells and promotes TLR7\/8 and IL-21 induced differentiation","author":"Zumaquero","year":"2019","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.autrev.2025.103821_bb0240","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/art.41913","article-title":"Effect of clonally expanded PD-1(high) CXCR5-CD4+ peripheral T helper cells on B cell differentiation in the joints of patients with antinuclear antibody-positive juvenile idiopathic arthritis","volume":"74","author":"Fischer","year":"2022","journal-title":"Arthritis Rheumatol"},{"issue":"20","key":"10.1016\/j.autrev.2025.103821_bb0245","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.130062","article-title":"PD-1hiCXCR5- T peripheral helper cells promote B cell responses in lupus via MAF and IL-21","volume":"4","author":"Bocharnikov","year":"2019","journal-title":"JCI Insight"},{"issue":"6","key":"10.1016\/j.autrev.2025.103821_bb0250","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/ard-2023-225284","article-title":"Novel endotypes of antisynthetase syndrome identified independent of anti-aminoacyl transfer RNA synthetase antibody specificity that improve prognostic stratification","volume":"83","author":"Wu","year":"2024","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2025.103821_bb0255","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"10.1016\/j.autrev.2025.103821_bb0260","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.4049\/jimmunol.1002795","article-title":"Type I interferon in the pathogenesis of lupus","volume":"192","author":"Crow","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2025.103821_bb0265","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.exger.2013.12.011","article-title":"Trafficking phenotype and production of granzyme B by double negative B cells (IgG(+)IgD(\u2212)CD27(\u2212)) in the elderly","volume":"54","author":"Bulati","year":"2014","journal-title":"Exp Gerontol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103821_bb0270","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191638","article-title":"Regulation of the germinal center and humoral immunity by interleukin-21","volume":"217","author":"Tangye","year":"2020","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2025.103821_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113787","article-title":"The PPAR-\u03b1 selective agonist WY14643 improves lupus nephritis via the downregulation of the ROR\u03b3T\/STAT3 signaling pathway in MRL\/lpr mice","volume":"145","author":"Al-Mazroua","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.autrev.2025.103821_bb0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2019.01.013","article-title":"Clinical significance and immunobiology of IL-21 in autoimmunity","volume":"99","author":"Long","year":"2019","journal-title":"J Autoimmun"},{"issue":"11","key":"10.1016\/j.autrev.2025.103821_bb0285","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.151614","article-title":"Blimp-1 molds the epigenetic architecture of IL-21-mediated autoimmune diseases through an autoregulatory circuit","volume":"7","author":"Liu","year":"2022","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.autrev.2025.103821_bb0290","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41392-024-02017-6","article-title":"2D4, a humanized monoclonal antibody targeting CD132, is a promising treatment for systemic lupus erythematosus","volume":"9","author":"Yin","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"7","key":"10.1016\/j.autrev.2025.103821_bb0295","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/s41590-024-01858-1","article-title":"IL-12 induces a B cell-intrinsic IL-12\/IFN\u03b3 feed-forward loop promoting extrafollicular B cell responses","volume":"25","author":"Elsner","year":"2024","journal-title":"Nat Immunol"},{"issue":"10155","key":"10.1016\/j.autrev.2025.103821_bb0300","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/S0140-6736(18)32167-6","article-title":"Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2, randomised, controlled study","volume":"392","author":"van Vollenhoven","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2025.103821_bb0305","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1305590","article-title":"Th1-related transcription factors and cytokines in systemic lupus erythematosus","volume":"14","author":"Tang","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2025.103821_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115611","article-title":"Discovery of WD-890: a novel allosteric TYK2 inhibitor for the treatment of multiple autoimmune diseases","volume":"167","author":"Fang","year":"2023","journal-title":"Biomed Pharmacother"},{"issue":"11","key":"10.1016\/j.autrev.2025.103821_bb0315","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15112881","article-title":"Combination of high-resolution structures for the B cell receptor and co-receptors provides an understanding of their interactions with therapeutic antibodies","volume":"15","author":"Bhattacharyya","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.autrev.2025.103821_bb0320","doi-asserted-by":"crossref","first-page":"40","DOI":"10.12703\/P5-40","article-title":"B lymphocyte antigen receptor signaling: initiation, amplification, and regulation","volume":"5","author":"Packard","year":"2013","journal-title":"F1000Prime Rep"},{"issue":"3","key":"10.1016\/j.autrev.2025.103821_bb0325","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nrc.2017.121","article-title":"Targeting B cell receptor signalling in cancer: preclinical and clinical advances","volume":"18","author":"Burger","year":"2018","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"10.1016\/j.autrev.2025.103821_bb0330","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/ni.1900","article-title":"Control systems and decision making for antibody production","volume":"11","author":"Goodnow","year":"2010","journal-title":"Nat Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2025.103821_bb0335","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nri1808","article-title":"ITAM-mediated tonic signalling through pre-BCR and BCR complexes","volume":"6","author":"Monroe","year":"2006","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2025.103821_bb0340","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1172\/JCI89931","article-title":"A TLR9-dependent checkpoint governs B cell responses to DNA-containing antigens","volume":"127","author":"Sindhava","year":"2017","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.autrev.2025.103821_bb0345","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1084\/jem.20022144","article-title":"B cell receptor-independent stimuli trigger immunoglobulin (Ig) class switch recombination and production of IgG autoantibodies by anergic self-reactive B cells","volume":"197","author":"Phan","year":"2003","journal-title":"J Exp Med"},{"issue":"8","key":"10.1016\/j.autrev.2025.103821_bb0350","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1177\/0961203316643172","article-title":"B-cell subsets, signaling and their roles in secretion of autoantibodies","volume":"25","author":"Iwata","year":"2016","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2025.103821_bb0355","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1093208","article-title":"Toll-like receptors 7 and 9 regulate the proliferation and differentiation of B cells in systemic lupus erythematosus","volume":"14","author":"Wen","year":"2023","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2025.103821_bb0360","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.pharmthera.2013.03.003","article-title":"Toll-like receptors as therapeutic targets for autoimmune connective tissue diseases","volume":"138","author":"Li","year":"2013","journal-title":"Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.autrev.2025.103821_bb0365","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41584-020-00544-4","article-title":"Toll-like receptor signalling in B cells during systemic lupus erythematosus","volume":"17","author":"Fillatreau","year":"2021","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2025.103821_bb0370","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.smim.2011.01.016","article-title":"Toll-like receptor driven B cell activation in the induction of systemic autoimmunity","volume":"23","author":"Green","year":"2011","journal-title":"Semin Immunol"},{"issue":"10","key":"10.1016\/j.autrev.2025.103821_bb0375","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.4049\/jimmunol.1400098","article-title":"Opposing impact of B cell-intrinsic TLR7 and TLR9 signals on autoantibody repertoire and systemic inflammation","volume":"192","author":"Jackson","year":"2014","journal-title":"J Immunol"},{"issue":"16","key":"10.1016\/j.autrev.2025.103821_bb0380","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.172219","article-title":"B cell-intrinsic TLR7 expression drives severe lupus in TLR9-deficient mice","volume":"8","author":"Cosgrove","year":"2023","journal-title":"JCI Insight"},{"issue":"7066","key":"10.1016\/j.autrev.2025.103821_bb0385","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nature04267","article-title":"Control of B-cell responses by toll-like receptors","volume":"438","author":"Pasare","year":"2005","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.autrev.2025.103821_bb0390","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nm.1894","article-title":"Lack of antibody affinity maturation due to poor toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease","volume":"15","author":"Delgado","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2025.103821_bb0395","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/1479-5876-10-251","article-title":"Expression of CXCL12 receptors in B cells from Mexican mestizos patients with systemic lupus erythematosus","volume":"10","author":"Biajoux","year":"2012","journal-title":"J Transl Med"},{"issue":"10","key":"10.1016\/j.autrev.2025.103821_bb0400","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/cmi.2016.47","article-title":"Contribution and underlying mechanisms of CXCR4 overexpression in patients with systemic lupus erythematosus","volume":"14","author":"Zhao","year":"2017","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103821_bb0405","first-page":"e71","article-title":"MIG in cutaneous systemic lupus erythematosus","volume":"170","author":"Ruffilli","year":"2019","journal-title":"Clin Ter"},{"issue":"7","key":"10.1016\/j.autrev.2025.103821_bb0410","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/s41590-019-0398-x","article-title":"The immune cell landscape in kidneys of patients with lupus nephritis","volume":"20","author":"Arazi","year":"2019","journal-title":"Nat Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2025.103821_bb0415","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202302465","article-title":"CXCR4: from B-cell development to B cell-mediated diseases","volume":"7","author":"Giorgiutti","year":"2024","journal-title":"Life Sci Alliance"},{"issue":"1","key":"10.1016\/j.autrev.2025.103821_bb0420","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1038\/s41467-024-46053-w","article-title":"Distinct transcriptomes and autocrine cytokines underpin maturation and survival of antibody-secreting cells in systemic lupus erythematosus","volume":"15","author":"Chen","year":"2024","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.autrev.2025.103821_bb0425","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.4049\/jimmunol.163.5.2378","article-title":"Cutting edge: a novel mechanism for rescue of B cells from CD95\/Fas-mediated apoptosis","volume":"163","author":"Catlett","year":"1999","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2025.103821_bb0430","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1080\/14728222.2018.1472768","article-title":"Update on Fc receptor-like (FCRL) family: new immunoregulatory players in health and diseases","volume":"22","author":"Rostamzadeh","year":"2018","journal-title":"Expert Opin Ther Targets"},{"issue":"7","key":"10.1016\/j.autrev.2025.103821_bb0435","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1177\/0961203314560424","article-title":"Increased Syk phosphorylation leads to overexpression of TRAF6 in peripheral B cells of patients with systemic lupus erythematosus","volume":"24","author":"Iwata","year":"2015","journal-title":"Lupus"},{"issue":"21","key":"10.1016\/j.autrev.2025.103821_bb0440","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16213574","article-title":"The immunomodulatory mechanisms of BTK inhibition in CLL and beyond","volume":"16","author":"Jiang","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"10","key":"10.1016\/j.autrev.2025.103821_bb0445","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1002\/art.41811","article-title":"Efficacy, safety, and pharmacodynamic effects of the Bruton\u2019s tyrosine kinase inhibitor Fenebrutinib (GDC-0853) in systemic lupus erythematosus: results of a phase II, randomized, double-blind, placebo-controlled trial","volume":"73","author":"Isenberg","year":"2021","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103821_bb0450","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jnnp-2022-328799","article-title":"Characterisation of the safety profile of evobrutinib in over 1000 patients from phase II clinical trials in multiple sclerosis, rheumatoid arthritis and systemic lupus erythematosus: an integrated safety analysis","volume":"94","author":"Montalban","year":"2023","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"10.1016\/j.autrev.2025.103821_bb0455","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1128\/MCB.20.5.1626-1638.2000","article-title":"Akt suppresses apoptosis by stimulating the transactivation potential of the RelA\/p65 subunit of NF-kappaB","volume":"20","author":"Madrid","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.autrev.2025.103821_bb0460","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3389\/fimmu.2012.00228","article-title":"Akt and mTOR in B cell activation and differentiation","volume":"3","author":"Limon","year":"2012","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2025.103821_bb0465","article-title":"Cellular mechanisms underlying B cell abnormalities in patients with gain-of-function mutations in the PIK3CD gene","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.autrev.2025.103821_bb0470","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1136\/annrheumdis-2019-215039","article-title":"Lupus-associated atypical memory B cells are mTORC1-hyperactivated and functionally dysregulated","volume":"78","author":"Wu","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.autrev.2025.103821_bb0475","doi-asserted-by":"crossref","first-page":"425","DOI":"10.4049\/jimmunol.1601908","article-title":"Metabolic reprogramming commits differentiation of human CD27(+)IgD(+) B cells to plasmablasts or CD27(\u2212)IgD(\u2212) cells","volume":"199","author":"Torigoe","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2025.103821_bb0480","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev-pathol-061020-050135","article-title":"Metabolic gatekeepers of pathological B cell activation","volume":"16","author":"Sadras","year":"2021","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.autrev.2025.103821_bb0485","article-title":"B cell metabolism in autoimmune diseases: signaling pathways and interventions","volume":"14","author":"Li","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2025.103821_bb0490","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.799788","article-title":"Gut microbiota dysbiosis in systemic lupus erythematosus: novel insights into mechanisms and promising therapeutic strategies","volume":"12","author":"Pan","year":"2021","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2025.103821_bb0495","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0092-8674(00)80702-3","article-title":"A novel transcription factor, T-bet, directs Th1 lineage commitment","volume":"100","author":"Szabo","year":"2000","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.autrev.2025.103821_bb0500","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1172\/JCI91250","article-title":"B cells expressing the transcription factor T-bet drive lupus-like autoimmunity","volume":"127","author":"Rubtsova","year":"2017","journal-title":"J Clin Invest"},{"issue":"6681","key":"10.1016\/j.autrev.2025.103821_bb0505","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1126\/science.adf8531","article-title":"The transcription factor ZEB2 drives the formation of age-associated B cells","volume":"383","author":"Dai","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.autrev.2025.103821_bb0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112077","article-title":"Roles of IRF4 in various immune cells in systemic lupus erythematosus","volume":"133","author":"Xiao","year":"2024","journal-title":"Int Immunopharmacol"},{"issue":"14","key":"10.1016\/j.autrev.2025.103821_bb0515","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1101\/gad.1104803","article-title":"IRF-4,8 orchestrate the pre-B-to-B transition in lymphocyte development","volume":"17","author":"Lu","year":"2003","journal-title":"Genes Dev"},{"issue":"7","key":"10.1016\/j.autrev.2025.103821_bb0520","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.it.2020.04.011","article-title":"Transcriptional control of mature B cell fates","volume":"41","author":"Wang","year":"2020","journal-title":"Trends Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2025.103821_bb0525","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/sj.cr.7310018","article-title":"IRF family proteins and type I interferon induction in dendritic cells","volume":"16","author":"Tailor","year":"2006","journal-title":"Cell Res"},{"issue":"15","key":"10.1016\/j.autrev.2025.103821_bb0530","article-title":"Monoallelic IRF5 deficiency in B cells prevents murine lupus","volume":"6","author":"Pellerin","year":"2021","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.autrev.2025.103821_bb0535","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2018-000296","article-title":"Cytoplasmic FOXO1 identifies a novel disease-activity associated B cell phenotype in SLE","volume":"5","author":"Hritzo Ahye","year":"2018","journal-title":"Lupus Sci Med"},{"issue":"10","key":"10.1016\/j.autrev.2025.103821_bb0540","doi-asserted-by":"crossref","first-page":"6624","DOI":"10.4049\/jimmunol.178.10.6624","article-title":"A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus","volume":"178","author":"Wei","year":"2007","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.autrev.2025.103821_bb0545","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24076578","article-title":"Advances in the pathogenesis and treatment of systemic lupus erythematosus","volume":"24","author":"Accapezzato","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.autrev.2025.103821_bb0550","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1038\/s41467-024-48267-4","article-title":"Double-negative B cells and DNASE1L3 colocalise with microbiota in gut-associated lymphoid tissue","volume":"15","author":"Montorsi","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2025.103821_bb0555","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fmed.2020.00085","article-title":"Double negative B cell is associated with renal impairment in systemic lupus erythematosus and acts as a marker for nephritis remission","volume":"7","author":"You","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.autrev.2025.103821_bb0560","doi-asserted-by":"crossref","first-page":"772","DOI":"10.3389\/fimmu.2019.00772","article-title":"Innate immune cells\u2019 contribution to systemic lupus erythematosus","volume":"10","author":"Herrada","year":"2019","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.autrev.2025.103821_bb0565","doi-asserted-by":"crossref","DOI":"10.1172\/JCI153580","article-title":"High-affinity autoreactive plasma cells disseminate through multiple organs in patients with immune thrombocytopenic purpura","volume":"132","author":"Canales-Herrerias","year":"2022","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.autrev.2025.103821_bb0570","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/bjh.18773","article-title":"B cells and antibodies in refractory immune thrombocytopenia","volume":"203","author":"Roeser","year":"2023","journal-title":"Br J Haematol"},{"key":"10.1016\/j.autrev.2025.103821_bb0575","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2024.1337339","article-title":"Peripheral memory B cells in multiple sclerosis vs. double negative B cells in neuromyelitis optica spectrum disorder: disease driving B cell subsets during CNS inflammation","volume":"18","author":"Tieck","year":"2024","journal-title":"Front Cell Neurosci"},{"issue":"5","key":"10.1016\/j.autrev.2025.103821_bb0580","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1007\/s10072-023-06629-8","article-title":"Analysis of LAP(+) and GARP(+) Treg subsets in peripheral blood of patients with neuromyelitis optica spectrum disorders","volume":"44","author":"Cai","year":"2023","journal-title":"Neurol Sci"},{"key":"10.1016\/j.autrev.2025.103821_bb0585","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1027158","article-title":"Granzyme B in circulating CD8+ T cells as a biomarker of immunotherapy effectiveness and disability in neuromyelitis optica spectrum disorders","volume":"13","author":"Shi","year":"2022","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2025.103821_bb0590","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/ni.2019","article-title":"Germinal center B and follicular helper T cells: siblings, cousins or just good friends?","volume":"12","author":"Nutt","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2025.103821_bb0595","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0065-2776(10)05007-8","article-title":"BCL6: master regulator of the germinal center reaction and key oncogene in B cell lymphomagenesis","volume":"105","author":"Basso","year":"2010","journal-title":"Adv Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2025.103821_bb0600","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/s41573-020-00092-2","article-title":"B cell depletion therapies in autoimmune disease: advances and mechanistic insights","volume":"20","author":"Lee","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.autrev.2025.103821_bb0605","article-title":"Two negative randomized controlled trials in lupus: now what?","volume":"1","author":"Coca","year":"2009","journal-title":"F1000 Med Rep"},{"issue":"12","key":"10.1016\/j.autrev.2025.103821_bb0610","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1002\/art.42652","article-title":"Obexelimab in systemic lupus erythematosus with exploration of response based on gene pathway co-expression patterns: a double-blind, randomized, placebo-controlled, phase 2 trial","volume":"75","author":"Merrill","year":"2023","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103821_bb0615","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s13287-023-03432-2","article-title":"hUC-MSC transplantation therapy effects on lupus-prone MRL\/lpr mice at early disease stages","volume":"14","author":"Guo","year":"2023","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"10.1016\/j.autrev.2025.103821_bb0620","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41420-022-01133-y","article-title":"CD95 gene deletion may reduce clonogenic growth and invasiveness of human glioblastoma cells in a CD95 ligand-independent manner","volume":"8","author":"Quijano-Rubio","year":"2022","journal-title":"Cell Death Dis"},{"issue":"10","key":"10.1016\/j.autrev.2025.103821_bb0625","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1012661","article-title":"Differences in phenotype between long-lived memory B cells against plasmodium falciparum merozoite antigens and variant surface antigens","volume":"20","author":"Reyes","year":"2024","journal-title":"PLoS Pathog"},{"issue":"482","key":"10.1016\/j.autrev.2025.103821_bb0630","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav1648","article-title":"Sustained B cell depletion by CD19-targeted CAR T cells is a highly effective treatment for murine lupus","volume":"11","author":"Kansal","year":"2019","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.autrev.2025.103821_bb0635","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/cei\/uxae031","article-title":"Disrupting B and T-cell collaboration in autoimmune disease: T-cell engagers versus CAR T-cell therapy?","volume":"217","author":"Shah","year":"2024","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103821_bb0640","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev-immunol-083122-044829","article-title":"B cell-directed therapy in autoimmunity","volume":"42","author":"Abeles","year":"2024","journal-title":"Annu Rev Immunol"},{"issue":"10","key":"10.1016\/j.autrev.2025.103821_bb0645","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/ard-2024-225785","article-title":"BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial","volume":"83","author":"Wang","year":"2024","journal-title":"Ann Rheum Dis"},{"issue":"10381","key":"10.1016\/j.autrev.2025.103821_bb0650","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0140-6736(22)02607-1","article-title":"Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-I)","volume":"401","author":"Morand","year":"2023","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.autrev.2025.103821_bb0655","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182927","article-title":"B-cell phenotype and IgD-CD27- memory B cells are affected by TNF-inhibitors and tocilizumab treatment in rheumatoid arthritis","volume":"12","author":"Moura","year":"2017","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.autrev.2025.103821_bb0660","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0952-7915(00)00205-3","article-title":"Selection events operating at various stages in B cell development","volume":"13","author":"Rolink","year":"2001","journal-title":"Curr Opin Immunol"},{"issue":"7","key":"10.1016\/j.autrev.2025.103821_bb0665","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/art.41208","article-title":"Methionine commits cells to differentiate into plasmablasts through epigenetic regulation of BTB and CNC homolog 2 by the methyltransferase EZH2","volume":"72","author":"Zhang","year":"2020","journal-title":"Arthritis Rheumatol"},{"issue":"33","key":"10.1016\/j.autrev.2025.103821_bb0670","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2303010120","article-title":"Ezh2 promotes mammary tumor initiation through epigenetic regulation of the Wnt and mTORC1 signaling pathways","volume":"120","author":"Liu","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.autrev.2025.103821_bb0675","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20221346","article-title":"Age-associated B cells are heterogeneous and dynamic drivers of autoimmunity in mice","volume":"220","author":"Nickerson","year":"2023","journal-title":"J Exp Med"},{"issue":"8","key":"10.1016\/j.autrev.2025.103821_bb0680","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s00018-022-04433-9","article-title":"Age-associated B cells in autoimmune diseases","volume":"79","author":"Mouat","year":"2022","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"10.1016\/j.autrev.2025.103821_bb0685","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1038\/s41467-024-45201-6","article-title":"T-bet(+) B cells are activated by and control endogenous retroviruses through TLR-dependent mechanisms","volume":"15","author":"Rauch","year":"2024","journal-title":"Nat Commun"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997225000813?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997225000813?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T22:06:05Z","timestamp":1762553165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997225000813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":137,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1568997225000813"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2025.103821","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of double-negative B cells in the pathogenesis of systemic lupus erythematosus","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2025.103821","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103821"}}